Quotes Charles River Laboratories International, Inc. Xetra
Equities
RV6
US1598641074
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
215.8 EUR | -2.40% | -.--% | -.--% |
06-13 | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
06-07 | The job report just threw a spanner in the works |
Performance
1 day | -2.40% | ||
3 years | -26.58% | ||
5 years | +862.76% | ||
10 years | +862.76% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-2.40% | -.--% | -.--% | -.--% | 10.79B | ||
-3.58% | -7.27% | +40.80% | +7.73% | 53.67B | ||
-0.17% | -3.98% | +35.79% | -14.93% | 38.86B | ||
-0.57% | -2.96% | -8.05% | -1.86% | 38.76B | ||
+0.44% | -4.03% | -8.98% | +11.76% | 27.27B | ||
-1.44% | -1.86% | +10.69% | +34.12% | 25.91B | ||
+0.21% | +4.98% | -16.21% | -20.73% | 20.29B | ||
+0.16% | +4.75% | +31.00% | +25.47% | 12.78B | ||
-0.05% | -1.81% | +28.51% | +78.55% | 12.18B | ||
-1.31% | -2.27% | -1.67% | -0.97% | 11.96B | ||
-2.33% | -5.60% | -5.43% | -11.83% | 9.39B | ||
-0.31% | +1.02% | +21.92% | -7.47% | 6.67B | ||
+8.78% | 0.00% | - | - | 6.65B | ||
-0.79% | +2.14% | +14.43% | +73.35% | 6.61B | ||
-2.82% | -4.26% | +34.66% | +53.62% | 6.37B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | -0.39% | -1.36% | +12.68% | +16.20% | ||
Weighted average by Cap. | -0.92% | -2.62% | +14.59% | +8.82% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2022 | -35.76% | ||
2021 | +1,398.66% | ||
2009 | -.--% |
- Stock Market
- Equities
- CRL Stock
- RV6 Stock
- Quotes Charles River Laboratories International, Inc.